Exelixis
EXEL----
Exelixis (EXEL)
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Exelixis Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$51.13-7.00%
Forecast & RatingBuy
19analysts
- Strong buy36.84%
- Buy5.26%
- Hold52.63%
- Sell0.00%
- Strong sell5.26%
News
- PUBT · 2 hours ago
Exelixis schedules quarterly results release and investor call
- Market Beat · Jul 16 at 04:44 AM
Exelixis, Inc. $EXEL Shares Bought by Three Seasons Wealth LLC
- Motley Fool · Jul 10 at 01:40 PM
3 Under-the-Radar Stocks to Buy and Hold
- Simplywall · Jun 26 at 02:54 PM
Is Exelixis (EXEL) Fully Valued On Its STELLAR 303 Trial Update?
- benzinga_article · Jun 25 at 09:17 AM
This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday
- Market Beat · Jun 24 at 08:06 AM
Citizens Jmp Forecasts Strong Price Appreciation for Exelixis (NASDAQ:EXEL) Stock
